We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+0.5%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$710M
AUM Growth
-$45.7M
Cap. Flow
-$39.7M
Cap. Flow %
-5.59%
Top 10 Hldgs %
9.53%
Holding
2,469
New
584
Increased
596
Reduced
458
Closed
638

Sector Composition

Rank Sector Weight
1 Technology 11.11%
2 Energy 9.76%
3 Consumer Discretionary 8.51%
4 Industrials 8.43%
5 Healthcare 7.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LVNTA
1076
DELISTED
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
$102K 0.01%
2,675
-122,392
-98% -$4.48M
FIG
1077
DELISTED
Fortress Investment Group Llc
FIG
$102K 0.01%
14,800
QADA
1078
DELISTED
QAD Inc.
QADA
$102K 0.01%
5,500
+2,200
+67% +$44.1K
BG icon
1079
Bunge Global
BG
$20.8B
$101K 0.01%
+1,200
New +$96.8K
NCLH icon
1080
PUT
Norwegian Cruise Line
NCLH
$8.84B
$101K 0.01%
+2,800
New +$95.1K
TUES
1081
DELISTED
Tuesday Morning Corp
TUES
$101K 0.01%
+5,200
New +$92.7K
DEST
1082
DELISTED
Destination Maternity Corporation
DEST
$101K 0.01%
+6,520
New +$130K
ASML icon
1083
ASML
ASML
$669B
$99K 0.01%
1,000
-1,500
-60% -$141K
CMCO icon
1084
Columbus McKinnon
CMCO
$584M
$99K 0.01%
+4,500
New +$113K
HHS icon
1085
Harte-Hanks
HHS
$99K 0.01%
1,560
-870
-36% -$59.1K
PINC
1086
DELISTED
Premier
PINC
$99K 0.01%
3,000
+2,800
+1,400% +$83.9K
ECYT
1087
DELISTED
Endocyte, Inc. Common Stock
ECYT
$99K 0.01%
16,326
-1,774
-10% -$12.1K
REGI
1088
DELISTED
Renewable Energy Group, Inc.
REGI
$99K 0.01%
9,800
-3,200
-25% -$35.9K
AAP icon
1089
Advance Auto Parts
AAP
$3.49B
$98K 0.01%
750
-2,050
-73% -$269K
BR icon
1090
Broadridge
BR
$19B
$98K 0.01%
2,363
+1,376
+139% +$57.2K
HOS
1091
DELISTED
Hornbeck Offshore Services, Inc.
HOS
$98K 0.01%
3,000
-31,639
-91% -$1.31M
PPS
1092
DELISTED
Post Properties
PPS
$98K 0.01%
+1,904
New +$103K
PCRX icon
1093
PUT
Pacira BioSciences
PCRX
$997M
$97K 0.01%
+1,000
New +$97.3K
RGR icon
1094
Sturm, Ruger & Co
RGR
$593M
$97K 0.01%
2,000
GNC
1095
DELISTED
GNC Holdings, Inc.
GNC
$97K 0.01%
2,500
-15,000
-86% -$545K
COF icon
1096
Capital One
COF
$134B
$96K 0.01%
1,172
+522
+80% +$42.7K
FN icon
1097
Fabrinet
FN
$20.1B
$96K 0.01%
+6,600
New +$115K
LVLT
1098
DELISTED
Level 3 Communications Inc
LVLT
$96K 0.01%
2,100
-4,297
-67% -$191K
SSRI
1099
DELISTED
Silver Standard Resources
SSRI
$96K 0.01%
+15,800
New +$135K
DFS
1100
DELISTED
Discover Financial Services
DFS
$95K 0.01%
1,475
-200
-12% -$12.5K

Similar funds

Prelude Capital Management's Q3 2014 Portfolio in Review

As of Q3 2014, Prelude Capital Management held 2,469 positions worth $710M, down 6% from $756M the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.

Prelude Capital Management withdrew a net $39.7M in Q3 2014, closing 638 positions and reducing 458 holdings. Its most notable exit was FOREST LABORATORIES INC, an estimated $5.64M position sold in full.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 9.1% a quarter earlier, followed by Energy and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in CONCUR TECHNOLOGIES INC worth $6.4M.

  • Prelude Capital Management's largest Q3 2014 buy was CONCUR TECHNOLOGIES INC: 50,447 shares worth $6.4M.
  • Prelude Capital Management added most to COVIDIEN PLC COM SHS NEW (IRELAND) in Q3 2014, an estimated $6.42M increase.
  • Prelude Capital Management's biggest Q3 2014 reduction was Liberty Interactive Corporation Series A Liberty Ventures, cutting an estimated $4.48M.
  • Prelude Capital Management fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $5.64M.
  • Prelude Capital Management's ten largest holdings make up 9.5% of its $710M portfolio in Q3 2014.
  • Prelude Capital Management opened 584 new positions and closed 638 in Q3 2014.
  • Prelude Capital Management's portfolio value fell 6% quarter-over-quarter to $710M.

Based on Prelude Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.